Literature DB >> 20829061

Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood.

Hiroyuki Eda1, Jian Zhang, Robert H Keith, Marshall Michener, David R Beidler, Joseph B Monahan.   

Abstract

The aim of this study is to investigate if macrophage-colony stimulating factor (M-CSF) or interleukin-34 (IL-34) induces cytokines or chemokines using human whole blood (HWB) and if an M-CSF- or IL-34-induced cytokine or chemokine production from HWB is inhibited by soluble M-CSF receptor or c-FMS kinase inhibitors. Among eight cytokines or growth factors tested, only IL-6 level was increased by up to 6-fold by M-CSF or IL-34 in HWB. In contrast, chemokine levels (IP-10/CXCL10, IL-8/CXCL8, and MCP-1/CCL2) were dramatically increased by M-CSF or IL-34 in HWB while exhibiting a large variation among donors. Variability of the MCP-1 signal induced by M-CSF or IL-34 was relatively less among donors compared to the IP-10 and IL-8 signals. The elevation of these chemokine levels was significantly decreased by soluble M-CSF receptor, indicating the elevation of these chemokines was mediated by M-CSF or IL-34. Furthermore, GW2580, a c-FMS kinase inhibitor, inhibited the induction of MCP-1 by M-CSF or IL-34 in a concentration dependent manner. These indicate MCP-1 is the most appropriate chemokine target for a chemokine release assay to evaluate the potency of c-FMS kinase inhibitors and MCP-1 release assay using HWB would be useful, relevant tool for translational pharmacology of c-FMS kinase inhibitors.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20829061     DOI: 10.1016/j.cyto.2010.08.005

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  26 in total

1.  IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.

Authors:  Yukihiro Wada; Hilda M Gonzalez-Sanchez; Julia Weinmann-Menke; Yasunori Iwata; Amrendra K Ajay; Myriam Meineck; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2019-01-08       Impact factor: 10.121

2.  Interleukin-34 induces monocytic-like differentiation in leukemia cell lines.

Authors:  Burthia E Booker; Ryan S Clark; Samuel T Pellom; Samuel E Adunyah
Journal:  Int J Biochem Mol Biol       Date:  2015-03-20

3.  Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis.

Authors:  Sung Hae Chang; Byoong Yong Choi; Jungbum Choi; Jong Jin Yoo; You-Jung Ha; Hyon Joung Cho; Eun Ha Kang; Yeong Wook Song; Yun Jong Lee
Journal:  Rheumatol Int       Date:  2014-06-11       Impact factor: 2.631

4.  Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients.

Authors:  M Chemel; B Le Goff; R Brion; C Cozic; M Berreur; J Amiaud; G Bougras; S Touchais; F Blanchard; M F Heymann; J M Berthelot; F Verrecchia; D Heymann
Journal:  Ann Rheum Dis       Date:  2011-10-28       Impact factor: 19.103

Review 5.  Functions of interleukin-34 and its emerging association with rheumatoid arthritis.

Authors:  Ren-Peng Zhou; Xiao-Shan Wu; Ya-Ya Xie; Bei-Bei Dai; Wei Hu; Jin-Fang Ge; Fei-Hu Chen
Journal:  Immunology       Date:  2016-09-23       Impact factor: 7.397

Review 6.  Immunoregulatory properties of the cytokine IL-34.

Authors:  Carole Guillonneau; Séverine Bézie; Ignacio Anegon
Journal:  Cell Mol Life Sci       Date:  2017-03-03       Impact factor: 9.261

7.  IL-34 is a Treg-specific cytokine and mediates transplant tolerance.

Authors:  Séverine Bézie; Elodie Picarda; Jason Ossart; Laurent Tesson; Claire Usal; Karine Renaudin; Ignacio Anegon; Carole Guillonneau
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

8.  Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production.

Authors:  Ye Tian; Hui Shen; Liping Xia; Jing Lu
Journal:  J Interferon Cytokine Res       Date:  2013-02-19       Impact factor: 2.607

9.  CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.

Authors:  David K Edwards; Kevin Watanabe-Smith; Angela Rofelty; Alisa Damnernsawad; Ted Laderas; Adam Lamble; Evan F Lind; Andy Kaempf; Motomi Mori; Mara Rosenberg; Amanda d'Almeida; Nicola Long; Anupriya Agarwal; David Tyler Sweeney; Marc Loriaux; Shannon K McWeeney; Jeffrey W Tyner
Journal:  Blood       Date:  2018-11-13       Impact factor: 22.113

10.  Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis.

Authors:  Seung-Jun Hwang; Bongkun Choi; Soon-Suk Kang; Jae-Ho Chang; Yong-Gil Kim; Yeon-Ho Chung; Dong Hyun Sohn; Min Wook So; Chang-Keun Lee; William H Robinson; Eun-Ju Chang
Journal:  Arthritis Res Ther       Date:  2012-01-20       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.